Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.72 USD | -2.61% | -3.20% | -24.19% |
May. 10 | UBS Adjusts Rocket Pharmaceuticals Price Target to $51 From $54, Maintains Buy Rating | MT |
May. 10 | Rocket Pharmaceuticals Says Blood Disorder Therapies Show Promise | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ROCKET PHARMACEUTICALS, INC. | Bio Therapeutic Drugs | -2.61% | -3.20% | -24.19% | +8.55% | +22.94% | 2.06B |
- Stock Market
- Equities
- RCKT Stock
- Charts Rocket Pharmaceuticals, Inc.
- Relative Strength Chart